[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"beskreve","PROBA":0.1252728365},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"\u05c1A eligible","PROBA":0.5885600203},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"\"))} A: eligible. The patient has mild Parkinson's disease (Hoehn-Yahr Stage I), which is not an exclusion criterion. Although the patient has a history of hypertension and hypercholesterolemia, these conditions do not preclude participation in the clinical trial. The patient is also alert and cooperative, and there are no signs of dementia, which satisfies the inclusion criteria.","PROBA":0.8251704696},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nAnswer:\n\nA) Eligible.\n\n{% Endraw %}\n\nRationale:\nThe patient's BMI of 41.5 and obesity as mentioned in the patient note satisfy the inclusion criteria of the clinical trial since the trial focuses on overweight and obese adults. The patient's medical history, including her use of antiobesity agents and appetite suppressants in the past, is also associated with the inclusion criteria. Additionally, the patient's serum uric acid concentrations and arterial stiffness will be evaluated, which aligns with the trial's primary outcome measures. Although the patient has occasional sleep apnea and PCO, these conditions do not disqualify or exclude her from the trial. As for the exclusion criteria, since she does not engage in moderate or vigorous-intensity physical activity (< 150 minutes per week of moderate-intensity, or < 75 minutes a week of vigorous-intensity aerobic physical activity, or an equivalent combination of both), and she has no known liver disease and no abnormal thyroid function (despite taking medication), and no fasting glucose \u2265 125 mg\/dL, she is eligible for the clinical trial. So, it is concluded that the patient is eligible for the study.","PROBA":0.7434062976},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"MDb: Eligible A","PROBA":0.4228422418}]
